This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 433
From Proteopedia
(→Overall Structure) |
|||
| Line 9: | Line 9: | ||
===Overall Structure=== | ===Overall Structure=== | ||
| - | <scene | + | <Structure load='1rhk' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' /> |
| + | |||
===Binding Interactions=== | ===Binding Interactions=== | ||
| Line 19: | Line 20: | ||
-Good drug candidates for inhibition | -Good drug candidates for inhibition | ||
| - | + | ||
| - | <scene name='Sandbox_Reserved_433/Binding_site_inhibitor_1/1'> | + | <scene name='Sandbox_Reserved_433/Binding_site_inhibitor_1/1'>Inhibitor 1</scene> |
===Additional Features=== | ===Additional Features=== | ||
Revision as of 04:23, 5 March 2012
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Contents |
Caspase 3- 1rhk
Introduction
what is caspase, what is caspase 3, the general structure and function, why we care.
Overall Structure
|
Binding Interactions
-Focus on difficulties in finding good inhibitors
-Chemical and conformational changes applied to various inhibitors
-Good drug candidates for inhibition
Additional Features
Credits
Introduction - Di Lin
Overall Structure - Austin Virtue
Drug Binding Site - Jill Moore
Additional Features - name of team member
